ArticleFrontiers in immunology2026
A semi-automated imaging and analysis pipeline for NET quantification and temporal-profiling of NETosis.
Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- CSF2 drives radiation-induced lung injury by eliciting PADI4-high pathogenic neutrophils.Journal of translational medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
NETosis is a distinct form of neutrophil cell death involved in innate immunity and characterized by the release of DNA, that when dysregulated contributes to tissue damage and target-organ injury. As our understanding of the mechanisms governing this process continues to advance, there is a growing need for refined tools that can precisely characterize NETosis and enable efficient screening of its modulators. Here, we present a novel live-cell imaging and analysis pipeline for quantifying NETosis in cultured cells. We have generated a CellProfiler pipeline that enables in-depth analysis of cell and NET features, allowing for subsequent characterization and classification of NETosis stages using machine learning. Coupled with high throughput live cell imaging, this approach allows for large-scale and automated tracking of NETosis progression. The pipeline was validated in promyelocytic HL-60 cells differentiated into granulocyte-like cells, as well as primary neutrophils from the bone marrow of mice. We further confirmed dose and stimulus-dependent responses to common stimuli and pharmacological inhibitors of NETosis. As a flexible and scalable high-throughput imaging pipeline, our novel approach allows for the assessment of NETting dynamics and the screening of potential NETosis-modulating agents, which will be instrumental in developing therapies for NET-induced tissue injury.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.